AKERS BIOSCIENCES INC
Q2 2020 13F Holders
CUSIP
00973E409
Type
Equity
Class
COM
Num filings
12
Total reported value, excl. options
$347 k
Compare 2020 Q2 to
2022 Q1
2021 Q1
2020 Q4
2020 Q3
2020 Q1
2019 Q4
2019 Q3
Manager
Report Date
Value ($000)
Shares
Option Type